SlideShare a Scribd company logo
MORTALITY MEETING 29 APRIL 2016
b/o jamuna nb /f/740gm CRN 201603276406
Tob 4;10pm dob 16/3/16
•
•NVD ,CIAB?,AUTO RICKSHAW DELIVERY,
• POG 25WEEK
G2P1L1
•RECEIVE IN GASPING
CONDITIONINTUBATED WITH ET TUBE NO
2 (BETTER TO PUT 2.5
ET tube sizes
Weight GA(weeks) Tube size(mm)
(internal diameter)
Below 1 kg 28 2.5
1-2 kg 28-34 3.0
2-3 kg 34-38 3.5
>3kg >38 3.5- 4.00
3
 STARDED IV FLUID 40ML 12 HRLY 5%
D(>100ML/KG/DAY) BETTER TO START80-90
ML/KG/DAY BCZ PT SHOULD GIVEN RESTRICTED
FLUID BCZ OVER FLUID MAY LED TO OPENING OF
PDA,NEC,BROCHOPULMONARY DYSPLASIA
 These PT have large insensible loss of fluid ,immature
skin barrier use of transparent plastic barrier
,application of coconut oil, use of double wall
incubator
 Monitor temp
 Inj vit K
 Shifted to nursery
 SURFACTENT
 NEW BALLARD SCORING
 RISK FACTOR IN MOTHER
 SEPTIC SCREEN
 CXR
RISK FACTOR FOR EONS
 1. Low birth weight (<2500 grams) or prematurity
 2. Febrile illness in the mother with evidence of bacterial infection within 2
weeks prior to
 delivery.
 3. Foul smelling and/or meconium stained liquor.
 4. Rupture of membranes >24 hours.
 5. Single unclean or > 3 sterile vaginal examination(s) during labor
 6. Prolonged labor (sum of 1st and 2nd stage of labor > 24 hrs)
 7. Perinatal asphyxia (Apgar score <4 at 1 minute)
 Presence of foul smelling liquor or three of the above mentioned risk factors
warrant initiation of
 antibiotic treatment. Infants with two risk factors should be investigated and
then treated accordingly
 Source:aiims protocol of neonatology
surfactant
 Natural
1. Minced lung extract a)surfactant TA(SURFACTEN)
b)beratant(SURVANTA)
c)poratent alfa (curosurf)
1. Lung lavage extract
2. Amniotic fluid extract
 Synthetic 0ld synthetic (Protein free)eg exocurf
new synthetic (protein analogue)eg
surfaxin
Indication of SRT
 RDS
 OTHER WHERE SURFACTANT IS INACTIVATED
SUCH AS MAS,PNEUMONIA,PULMONARY
HAEMOORRHAE,CDH,ARDS
 IN RDS IT IS GIVEN AS PROPHYLACTIC OR AS
RESCUE THERAPY
 PROPHYLACTICALLY : IN DELIVERY ROOM
WITHIN 15 MIN
 EARLY RESCUE ;WITHIN 2 HR IF RDS DEVELOP
 LATE RESCUE: >2 HR DONE IN OUTDOOR PT
REFFERED FROM OUTSIDE
DOSE
 SURVANTA (DOSE phospho lipid )4ml/kg
100mg/kg
 CUROSURF (dose phospholipid)2.5ML/KG
200MG/KG
 NEOSURF (dose phospholipid)5ML/KG 135MG/KG
PROCEDURE
 EXPERIENCE PHYSICIAN(who can anticipate
,recognize ,t/t complication of surfactant)
 WARM DO NOT SHAKEINTUBATE ASSES
BREATH SOUND-CONNECT TO PULSE
OXIMETER->INSERT FEEDING TUBE SUCH THAT
TIP PROJECT BEYOND ET TUBE->surfactant given as
bolus in four aliquots -> connect the infant to
ventilator, T piece, resuscitation bag till saturation and
heart rate stabilizes before administering next aliquot
 No position change is required
 Avoid suction at least 2 hr after administration
Septic screen
the sepsis screen consists of 5 items: C-reactive protein
(CRP), absolute
neutrophil count (ANC), immature to total neutrophil ratio
(ITR) and micro-erythrocyte
sedimentation rate (μ-ESR).TLC
• CRP: Quantitative CRP assayed by nephelometry is superior
to CRP by ELISA and semiquantitative
CRP by a latex agglutination kit. Cut-off value for
quantitative assay is 10 mg/L.
• ANC: It must be low count as per Manroe’s charts or
Mouzinho’s chart, depending on whether it is a term
baby or a preterm baby respectively .
• Immature /total neutrophil ≥0.2
• μ-ESR. Value ≥ 15mm in first hrs
TLC (TOTAL LEUKOCYTE COUNT) <5000/MM₃
Source:aiims protocol of neonatology
NEW BALLARD SCORING
Neonatal Gestational Age
Physical Maturity
Neonatal Gestational Age
Neuromuscular Assessment
SCORE WEEKS
-10 20 50 44
-5 22
0 24
5 26
10 28
15 30
20 32
25 34
30 36
35 38
40 40
45 42
CXR
RDS
Low volume lung
Fine reticulogranular pattern
Ground glass apperence
Air bronchogram
White out lung
RUL pneumonia
Meconium Aspiration Syndrome
Hyper inflated lung,
Coarse nodular fluffy
opacity
Patchy atelactesis
Area of over inflation
 BABY PUT ON VENTILLATORY SUPPORT-
>SETTING WAS
 PRVC MODE PEEP 5CM, TV 10,RATE 50,FIO2 80%
 COMMENT ON VENTILLATORY SETTING
->IN TAXIM
INJ AMIKACIN SHOULD ALSO BE STARTED
@18MG/KG/DOSE EVERY 48 HR DOSE IS FOR
<29WEEK
 VBG
Ph - 7.235 (acidosis)
pCO2 - 29.5 mm Hg, pO2 - 30.1 mm Hg
HCO3 - 12.2
->METABOLIC ACIDOSIS->I/V NS 7.5CC SLOWLY OVER ½
HR --.>IV AMIKACIN STARTED (DOSE IS NOT AS PER
AIIMS PROTOCOL @18 MG/KG/DOSE EVERY 48 HRLY
SAME CONDITION CONTINUE
BUT NO MONITORING OF SPO2 BCZ FIO2 increase to
90%, other setting same
 Skin mottling is there I/V BOLUS 10ML/KG +DOPAMINE
@10MICROGRAM/KG/MIN,ET ALSO CHANGE
 NNR,TONE,ACTIVITY-----NIL
 RD STARTED RR 58,RETRACTION PRESENT,CFT
4SEC,SPO2 88% with fio2 100%
 SIMV MODE STARTED PEEP 5,TV 10,FIO2 100%
 DOWNY YA SILWERMAN SCORING SHOULD BE DONE
FOR ASSESSMENT OF RESPIRATORY DISTRESS
SILVERMAN- ANDERSON
RETRACTION SCORE FOR
PRETERMS
 Started adrenaline infusion @.2 microgram /kg/hr
 7am baby develop cardiac arrest chest
compression inj adr @.1ml/kg(1:10,000) iv twice
 But second dose should be .2ml/kg
 Cpr continue (TIME NOT MENTION)
 7:25AM DECLARED DEATH
 THANK YOU

More Related Content

Viewers also liked

Viewers also liked (13)

Encontro SBGC - GESTÃO DO CONHECIMENTO E DA INFORMAÇÃO
 Encontro SBGC - GESTÃO DO CONHECIMENTO E DA INFORMAÇÃO Encontro SBGC - GESTÃO DO CONHECIMENTO E DA INFORMAÇÃO
Encontro SBGC - GESTÃO DO CONHECIMENTO E DA INFORMAÇÃO
 
Exercițiu tic
Exercițiu ticExercițiu tic
Exercițiu tic
 
Just Christians (A promise of a new name)
Just Christians (A promise of a new name)Just Christians (A promise of a new name)
Just Christians (A promise of a new name)
 
PSOL protocola impeachment de Michel Temer
PSOL protocola impeachment de Michel TemerPSOL protocola impeachment de Michel Temer
PSOL protocola impeachment de Michel Temer
 
Butterworth meeting practical evangelism 14-11-15
Butterworth meeting practical evangelism  14-11-15Butterworth meeting practical evangelism  14-11-15
Butterworth meeting practical evangelism 14-11-15
 
25 years interface management
25 years interface management25 years interface management
25 years interface management
 
Nano advertising campaign presentation
Nano advertising campaign  presentationNano advertising campaign  presentation
Nano advertising campaign presentation
 
Project Management 5 Cost Management
Project Management 5 Cost ManagementProject Management 5 Cost Management
Project Management 5 Cost Management
 
Encontro SBGC - Maturidade em Gestão do Conhecimento
Encontro SBGC - Maturidade em Gestão do ConhecimentoEncontro SBGC - Maturidade em Gestão do Conhecimento
Encontro SBGC - Maturidade em Gestão do Conhecimento
 
Nigel Tufnel's Guide to Local SEO That Rocks
Nigel Tufnel's Guide to Local SEO That RocksNigel Tufnel's Guide to Local SEO That Rocks
Nigel Tufnel's Guide to Local SEO That Rocks
 
A Fast & Furious Guide to Local SEO
A Fast & Furious Guide to Local SEOA Fast & Furious Guide to Local SEO
A Fast & Furious Guide to Local SEO
 
The Amazing SEM & SEO Show, starring the Beard & the Hair
The Amazing SEM & SEO Show, starring the Beard & the HairThe Amazing SEM & SEO Show, starring the Beard & the Hair
The Amazing SEM & SEO Show, starring the Beard & the Hair
 
Verbos griego clásico
Verbos griego clásicoVerbos griego clásico
Verbos griego clásico
 

Similar to New microsoft office power point presentation

NNF ready reckoner.pdf
NNF ready reckoner.pdfNNF ready reckoner.pdf
NNF ready reckoner.pdf
KickKick6
 
Extraction genomic dna
Extraction genomic dnaExtraction genomic dna
Extraction genomic dna
Modhafar Qader
 
Ventilation strategies in ards rachmale
Ventilation strategies in ards   rachmaleVentilation strategies in ards   rachmale
Ventilation strategies in ards rachmale
Dang Thanh Tuan
 
Ventilatory management of ards kacmarek
Ventilatory management of ards   kacmarekVentilatory management of ards   kacmarek
Ventilatory management of ards kacmarek
Dang Thanh Tuan
 
39 pasko pcrrt drug dosing
39 pasko   pcrrt drug dosing39 pasko   pcrrt drug dosing
39 pasko pcrrt drug dosing
Dang Thanh Tuan
 
Phylogenetics of the Grass Family
Phylogenetics of the Grass FamilyPhylogenetics of the Grass Family
Phylogenetics of the Grass Family
Vishnu Mohanan
 

Similar to New microsoft office power point presentation (20)

NNF ready reckoner.pdf
NNF ready reckoner.pdfNNF ready reckoner.pdf
NNF ready reckoner.pdf
 
BASIC ICU & OT NOTES 2021 (VERSION 3) FINAL.pdf
BASIC ICU & OT NOTES 2021 (VERSION 3) FINAL.pdfBASIC ICU & OT NOTES 2021 (VERSION 3) FINAL.pdf
BASIC ICU & OT NOTES 2021 (VERSION 3) FINAL.pdf
 
Extraction genomic dna
Extraction genomic dnaExtraction genomic dna
Extraction genomic dna
 
hemodialisys HFCRevCCCourseMcGill2000 ccv
hemodialisys HFCRevCCCourseMcGill2000 ccvhemodialisys HFCRevCCCourseMcGill2000 ccv
hemodialisys HFCRevCCCourseMcGill2000 ccv
 
Dr. Robert Langer - Simposio Internacional 'Terapias oncológicas avanzadas'
Dr. Robert Langer - Simposio Internacional 'Terapias oncológicas avanzadas'Dr. Robert Langer - Simposio Internacional 'Terapias oncológicas avanzadas'
Dr. Robert Langer - Simposio Internacional 'Terapias oncológicas avanzadas'
 
Ventilation strategies in ards rachmale
Ventilation strategies in ards   rachmaleVentilation strategies in ards   rachmale
Ventilation strategies in ards rachmale
 
Ventilatory management of ards kacmarek
Ventilatory management of ards   kacmarekVentilatory management of ards   kacmarek
Ventilatory management of ards kacmarek
 
meningitis case presentation
meningitis case presentationmeningitis case presentation
meningitis case presentation
 
Analysis of Phenolic Antioxidants in Edible Oil/Shortening Using the PerkinEl...
Analysis of Phenolic Antioxidants in Edible Oil/Shortening Using the PerkinEl...Analysis of Phenolic Antioxidants in Edible Oil/Shortening Using the PerkinEl...
Analysis of Phenolic Antioxidants in Edible Oil/Shortening Using the PerkinEl...
 
39 pasko pcrrt drug dosing
39 pasko   pcrrt drug dosing39 pasko   pcrrt drug dosing
39 pasko pcrrt drug dosing
 
Massive Transfusion in Trauma
Massive Transfusion in TraumaMassive Transfusion in Trauma
Massive Transfusion in Trauma
 
project ppt
project pptproject ppt
project ppt
 
PediRefCard.pdf
PediRefCard.pdfPediRefCard.pdf
PediRefCard.pdf
 
Laboratory investigations in coagulation disorders
Laboratory investigations in coagulation disordersLaboratory investigations in coagulation disorders
Laboratory investigations in coagulation disorders
 
Overview of Summer Internship Projects
Overview of Summer Internship ProjectsOverview of Summer Internship Projects
Overview of Summer Internship Projects
 
renal_system_lecture_2_Physiology_29_01_2019.pdf
renal_system_lecture_2_Physiology_29_01_2019.pdfrenal_system_lecture_2_Physiology_29_01_2019.pdf
renal_system_lecture_2_Physiology_29_01_2019.pdf
 
Interim Report
Interim ReportInterim Report
Interim Report
 
Ards
ArdsArds
Ards
 
CHRONIC KIDNEY DISEASE WITH NEUROGLYCOPENIA
CHRONIC KIDNEY DISEASE WITH NEUROGLYCOPENIACHRONIC KIDNEY DISEASE WITH NEUROGLYCOPENIA
CHRONIC KIDNEY DISEASE WITH NEUROGLYCOPENIA
 
Phylogenetics of the Grass Family
Phylogenetics of the Grass FamilyPhylogenetics of the Grass Family
Phylogenetics of the Grass Family
 

More from Mahtab Alam

More from Mahtab Alam (18)

Hypothyroidism
HypothyroidismHypothyroidism
Hypothyroidism
 
NEONATAL TRANSPORT IN INDIA
NEONATAL TRANSPORT IN INDIANEONATAL TRANSPORT IN INDIA
NEONATAL TRANSPORT IN INDIA
 
NEONATAL JAUNDICE
NEONATAL JAUNDICENEONATAL JAUNDICE
NEONATAL JAUNDICE
 
Neonatal sepsis
Neonatal sepsisNeonatal sepsis
Neonatal sepsis
 
Hypoglycemia
HypoglycemiaHypoglycemia
Hypoglycemia
 
New microsoft power point presentation
New microsoft power point presentationNew microsoft power point presentation
New microsoft power point presentation
 
Diarrhoea
DiarrhoeaDiarrhoea
Diarrhoea
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
 
Neonatal seizure (2)
Neonatal seizure (2)Neonatal seizure (2)
Neonatal seizure (2)
 
Febrile seizure
Febrile seizureFebrile seizure
Febrile seizure
 
Dengue recent update
Dengue recent updateDengue recent update
Dengue recent update
 
Bronchiolitis
BronchiolitisBronchiolitis
Bronchiolitis
 
Rta dr mahtab
Rta dr mahtabRta dr mahtab
Rta dr mahtab
 
New born resuscitation power point presentation
New born resuscitation power point presentationNew born resuscitation power point presentation
New born resuscitation power point presentation
 
dr Mahtab
 dr Mahtab dr Mahtab
dr Mahtab
 
portal hypertension and upper G I bleeding
portal hypertension and upper G I bleedingportal hypertension and upper G I bleeding
portal hypertension and upper G I bleeding
 
Urinary tract infection dr.m - copy
Urinary tract infection dr.m - copyUrinary tract infection dr.m - copy
Urinary tract infection dr.m - copy
 
kawasaki syndrome
kawasaki syndromekawasaki syndrome
kawasaki syndrome
 

Recently uploaded

New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
Mastering Wealth: A Path to Financial Freedom
Mastering Wealth: A Path to Financial FreedomMastering Wealth: A Path to Financial Freedom
Mastering Wealth: A Path to Financial Freedom
FatimaMary4
 

Recently uploaded (20)

Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf
1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf
1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf
 
5cl adbb 5cladba cheap and fine Telegram: +85297504341
5cl adbb 5cladba cheap and fine Telegram: +852975043415cl adbb 5cladba cheap and fine Telegram: +85297504341
5cl adbb 5cladba cheap and fine Telegram: +85297504341
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
Blue Printing in medical education by Dr.Mumtaz Ali.pptx
Blue Printing in medical education by Dr.Mumtaz Ali.pptxBlue Printing in medical education by Dr.Mumtaz Ali.pptx
Blue Printing in medical education by Dr.Mumtaz Ali.pptx
 
Temporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptx
Temporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptxTemporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptx
Temporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptx
 
Multiple sclerosis diet.230524.ppt3.pptx
Multiple sclerosis diet.230524.ppt3.pptxMultiple sclerosis diet.230524.ppt3.pptx
Multiple sclerosis diet.230524.ppt3.pptx
 
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptxCURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
 
"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t..."Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
 
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
 
TEST BANK For Advanced Practice Nursing in the Care of Older Adults, 2nd Edit...
TEST BANK For Advanced Practice Nursing in the Care of Older Adults, 2nd Edit...TEST BANK For Advanced Practice Nursing in the Care of Older Adults, 2nd Edit...
TEST BANK For Advanced Practice Nursing in the Care of Older Adults, 2nd Edit...
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
Mastering Wealth: A Path to Financial Freedom
Mastering Wealth: A Path to Financial FreedomMastering Wealth: A Path to Financial Freedom
Mastering Wealth: A Path to Financial Freedom
 
TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...
TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...
TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...
 
180-hour Power Capsules For Men In Ghana
180-hour Power Capsules For Men In Ghana180-hour Power Capsules For Men In Ghana
180-hour Power Capsules For Men In Ghana
 
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxPT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
 
Antiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPTAntiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPT
 
Factors Affecting child behavior in Pediatric Dentistry
Factors Affecting child behavior in Pediatric DentistryFactors Affecting child behavior in Pediatric Dentistry
Factors Affecting child behavior in Pediatric Dentistry
 

New microsoft office power point presentation

  • 1. MORTALITY MEETING 29 APRIL 2016
  • 2. b/o jamuna nb /f/740gm CRN 201603276406 Tob 4;10pm dob 16/3/16 • •NVD ,CIAB?,AUTO RICKSHAW DELIVERY, • POG 25WEEK G2P1L1 •RECEIVE IN GASPING CONDITIONINTUBATED WITH ET TUBE NO 2 (BETTER TO PUT 2.5
  • 3. ET tube sizes Weight GA(weeks) Tube size(mm) (internal diameter) Below 1 kg 28 2.5 1-2 kg 28-34 3.0 2-3 kg 34-38 3.5 >3kg >38 3.5- 4.00 3
  • 4.  STARDED IV FLUID 40ML 12 HRLY 5% D(>100ML/KG/DAY) BETTER TO START80-90 ML/KG/DAY BCZ PT SHOULD GIVEN RESTRICTED FLUID BCZ OVER FLUID MAY LED TO OPENING OF PDA,NEC,BROCHOPULMONARY DYSPLASIA  These PT have large insensible loss of fluid ,immature skin barrier use of transparent plastic barrier ,application of coconut oil, use of double wall incubator
  • 5.  Monitor temp  Inj vit K  Shifted to nursery  SURFACTENT  NEW BALLARD SCORING  RISK FACTOR IN MOTHER  SEPTIC SCREEN  CXR
  • 6. RISK FACTOR FOR EONS  1. Low birth weight (<2500 grams) or prematurity  2. Febrile illness in the mother with evidence of bacterial infection within 2 weeks prior to  delivery.  3. Foul smelling and/or meconium stained liquor.  4. Rupture of membranes >24 hours.  5. Single unclean or > 3 sterile vaginal examination(s) during labor  6. Prolonged labor (sum of 1st and 2nd stage of labor > 24 hrs)  7. Perinatal asphyxia (Apgar score <4 at 1 minute)  Presence of foul smelling liquor or three of the above mentioned risk factors warrant initiation of  antibiotic treatment. Infants with two risk factors should be investigated and then treated accordingly  Source:aiims protocol of neonatology
  • 7. surfactant  Natural 1. Minced lung extract a)surfactant TA(SURFACTEN) b)beratant(SURVANTA) c)poratent alfa (curosurf) 1. Lung lavage extract 2. Amniotic fluid extract  Synthetic 0ld synthetic (Protein free)eg exocurf new synthetic (protein analogue)eg surfaxin
  • 8. Indication of SRT  RDS  OTHER WHERE SURFACTANT IS INACTIVATED SUCH AS MAS,PNEUMONIA,PULMONARY HAEMOORRHAE,CDH,ARDS  IN RDS IT IS GIVEN AS PROPHYLACTIC OR AS RESCUE THERAPY
  • 9.
  • 10.  PROPHYLACTICALLY : IN DELIVERY ROOM WITHIN 15 MIN  EARLY RESCUE ;WITHIN 2 HR IF RDS DEVELOP  LATE RESCUE: >2 HR DONE IN OUTDOOR PT REFFERED FROM OUTSIDE
  • 11. DOSE  SURVANTA (DOSE phospho lipid )4ml/kg 100mg/kg  CUROSURF (dose phospholipid)2.5ML/KG 200MG/KG  NEOSURF (dose phospholipid)5ML/KG 135MG/KG
  • 12. PROCEDURE  EXPERIENCE PHYSICIAN(who can anticipate ,recognize ,t/t complication of surfactant)  WARM DO NOT SHAKEINTUBATE ASSES BREATH SOUND-CONNECT TO PULSE OXIMETER->INSERT FEEDING TUBE SUCH THAT TIP PROJECT BEYOND ET TUBE->surfactant given as bolus in four aliquots -> connect the infant to ventilator, T piece, resuscitation bag till saturation and heart rate stabilizes before administering next aliquot  No position change is required  Avoid suction at least 2 hr after administration
  • 13. Septic screen the sepsis screen consists of 5 items: C-reactive protein (CRP), absolute neutrophil count (ANC), immature to total neutrophil ratio (ITR) and micro-erythrocyte sedimentation rate (μ-ESR).TLC • CRP: Quantitative CRP assayed by nephelometry is superior to CRP by ELISA and semiquantitative CRP by a latex agglutination kit. Cut-off value for quantitative assay is 10 mg/L. • ANC: It must be low count as per Manroe’s charts or Mouzinho’s chart, depending on whether it is a term baby or a preterm baby respectively .
  • 14. • Immature /total neutrophil ≥0.2 • μ-ESR. Value ≥ 15mm in first hrs TLC (TOTAL LEUKOCYTE COUNT) <5000/MM₃ Source:aiims protocol of neonatology
  • 18. SCORE WEEKS -10 20 50 44 -5 22 0 24 5 26 10 28 15 30 20 32 25 34 30 36 35 38 40 40 45 42
  • 19. CXR
  • 20. RDS Low volume lung Fine reticulogranular pattern Ground glass apperence Air bronchogram White out lung
  • 22. Meconium Aspiration Syndrome Hyper inflated lung, Coarse nodular fluffy opacity Patchy atelactesis Area of over inflation
  • 23.  BABY PUT ON VENTILLATORY SUPPORT- >SETTING WAS  PRVC MODE PEEP 5CM, TV 10,RATE 50,FIO2 80%  COMMENT ON VENTILLATORY SETTING ->IN TAXIM INJ AMIKACIN SHOULD ALSO BE STARTED @18MG/KG/DOSE EVERY 48 HR DOSE IS FOR <29WEEK
  • 24.  VBG Ph - 7.235 (acidosis) pCO2 - 29.5 mm Hg, pO2 - 30.1 mm Hg HCO3 - 12.2 ->METABOLIC ACIDOSIS->I/V NS 7.5CC SLOWLY OVER ½ HR --.>IV AMIKACIN STARTED (DOSE IS NOT AS PER AIIMS PROTOCOL @18 MG/KG/DOSE EVERY 48 HRLY SAME CONDITION CONTINUE BUT NO MONITORING OF SPO2 BCZ FIO2 increase to 90%, other setting same
  • 25.  Skin mottling is there I/V BOLUS 10ML/KG +DOPAMINE @10MICROGRAM/KG/MIN,ET ALSO CHANGE  NNR,TONE,ACTIVITY-----NIL  RD STARTED RR 58,RETRACTION PRESENT,CFT 4SEC,SPO2 88% with fio2 100%  SIMV MODE STARTED PEEP 5,TV 10,FIO2 100%  DOWNY YA SILWERMAN SCORING SHOULD BE DONE FOR ASSESSMENT OF RESPIRATORY DISTRESS
  • 27.  Started adrenaline infusion @.2 microgram /kg/hr  7am baby develop cardiac arrest chest compression inj adr @.1ml/kg(1:10,000) iv twice  But second dose should be .2ml/kg  Cpr continue (TIME NOT MENTION)  7:25AM DECLARED DEATH